Abstract
We have investigated the suitability of five different commercially available kits which provide human serum albumin (HSA) labelled with technetium 99m (99mTc) for cardiac blood pool imaging. Four of these products were one-step processes using stannous chloride as the reducing agent; the fifth was based on an electrolytic reduction. In addition, we also assessed our own modification of the electrolytic method.
We measured the radiochemical purity by precipitation with trichloroacetic acid and by gel filtration on a Biogel P4 column. In addition, we measured the clearance of radioactivity from the blood at frequent time intervals after intravenous injection.
Each product was assessed in separate groups of six patients. The labelling efficiency of the one-step kits varied between 73 and 93% compared with 94 and 98% for the electrolytically labelled albumin. The blood clearance for all one-step kits was significantly faster than that obtained for the radiopharmaceuticals prepared by the electrolytic method. We conclude that HSA labelled with99mTc by the electrolytic method is to be preferred.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alpert, N.M., McKusick, M.A., Pohost, G.M., Dinemore, R.E., Potsaid, M.S.: Noninvasive nuclear kinecardiography. J. Nucl. Med.15, 1182–1184 (1974)
Benjamin, P.P.: A rapid and efficient method of preparing99mTc-human serum albumin: its clinical applications. Int. J. Appl. Radiat. Isot.20, 187–194 (1969)
Billinghurst, M.W.: Chromatographic quality control of99mTc-labelled compounds. J. Nucl. Med.14, 793–797 (1973)
Billinghurst, M.W., Palser, R.F.: Gel chromatography as an analytical tool for99mTc radiopharmaceuticals. J. Nucl. Med.15, 722–723 (1974)
Callahan, R.J., McKusick, K.A., Lamson, M., Castronovo, F.P., Potsaid, M.S.: Technetium 99m-human serum albumin: Evaluation of a commercially produced kit. J. Nucl. Med.17, 47–49 (1976)
Dworkin, H.J., Gutkowski, R.F.: Rapid closed system production of99mTc-albumin using electrolysis. J. Nucl. Med.12, 562–565 (1971)
Eckelman, W.C., Richards, P.: Analytical Pitfalls with99mTc-labelled compounds. J. Nucl. Med.13, 202–204 (1972)
Eckelman, W.C., Meinken, G., Richards, P.:99mTc-Human Serum Albumin. J. Nucl. Med.12, 707–710 (1971)
Lamson, L., Callahan, R.J., Castronovo, F.P., McKusick, K.A., Potsaid, M.S.: A rapid index of free activity in preparation of99mTc-albumin. J. Nucl. Med.15, 1061–1062 (1974)
Muir, A.L., Hannan, W.J., Brash, H.M., Baldwa, V., Miller, H.C., Ogilvie, B.: The assessment of left ventricular ejection fraction in patients with ischaemic heart disease by contrast ventriculography and nuclear angiography. Clin. Sci. Molec. Med.53, 55–61 (1977)
Porter, W.C., Dworkin, H.J., Gutkowski, R.F.: The effect of carrier technetium in the preparation of99mTc-human serum albumin. J. Nucl. Med.17, 704–706 (1976)
Secker-Walker, R.H., Resnick, L., Kunz, H., Parker, J.A., Hill, R.L., Potchen, E.J.: Measurement of left ventricular ejection fraction. J. Nucl. Med.14, 798–802 (1973)
Strauss, H.W., Zaret, B.L., Hurley, P.J., Natarajan, T.K., Pitt, B.: A scintiphotographic method for measuring left ventricular ejection fraction in man without cardiac catheterisation. Am. J. Cardiol.,28, 575–580 (1971)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Millar, A.M., Hannan, W.J., Sapru, R.P. et al. An evaluation of six kits of technetium 99m human serum albumin injection for cardiac blood pool imaging. Eur J Nucl Med 4, 91–94 (1979). https://doi.org/10.1007/BF00626077
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00626077